Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

Vascular dysfunction, low-grade inflammation, insulin resistance, and impaired fibrinolysis have each been reported to be present in type 2 diabetes, but their relationships, and the role of obesity, have not been investigated. We measured insulin sensitivity (euglycemic clamp), forearm blood flow responses to graded local acetylcholine (Ach) and sodium nitroprusside (SNP) infusions, plasma concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, von Willebrand factor (vWF), plasminogen activator inhibitor (PAI)-1, tissue plasminogen activator (tPA), and high-sensitivity C-reactive protein (hs-CRP) in 81 diabetic patients. When patients were stratified by insulin resistance, more severe insulin resistance was associated (P < 0.05) with overweight, central fat distribution, hypertension, and dyslipidemia (with similar sex distribution, age, fasting plasma glucose, and HbA1c). With regard to vascular function, both endothelium-dependent (Ach) (-22, -40, and -52%; P < 0.0001) and -independent (SNP) (-3, -7, and -27%; P < 0.02) vasodilatation were progressively reduced across insulin resistance tertiles. In multivariate analysis, inflammatory markers (IL-6, hs-CRP, and TNF-alpha) were independently associated with insulin resistance and fasting glycemia, fibrinolytic markers PAI-1 and tPA with insulin resistance and central fat distribution, and vascular indexes (vWF, Ach, and SNP vasodilation) with insulin resistance and obesity or cytokines (TNF-alpha or IL-6). In type 2 diabetes, insulin resistance is associated with vascular dysfunction/damage, impaired fibrinolysis, and low-grade inflammation independently of obesity and poor glycemic control.

[1]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[2]  E. Ford.  The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. , 2004, Atherosclerosis.

[3]  M. Rutter,et al.  C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study , 2004, Circulation.

[4]  S. Jacob,et al.  Insulin Resistance, Hyperinsulinemia, and Blood Pressure Role of Age and Obesity , 1997 .

[5]  A. Aljada,et al.  Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .

[6]  M. Taskinen,et al.  Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. , 1999, Diabetes care.

[7]  P. Savage,et al.  Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. , 2004, Diabetes.

[8]  R. Bergholm,et al.  Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects , 1996, Diabetologia.

[9]  E. Bonora,et al.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[10]  A. Aljada,et al.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? , 2001, The Journal of clinical endocrinology and metabolism.

[11]  A. Baron,et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.

[12]  T. Meinertz,et al.  Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus , 2000, Diabetologia.

[13]  E. Ferrannini,et al.  Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. , 2004, Diabetes care.

[14]  A. Baron,et al.  Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. , 2000, Diabetes.

[15]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. , 2001, Diabetes care.

[16]  L. Heilbronn,et al.  C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. , 2002, The Journal of nutritional biochemistry.

[17]  J. Westerbacka,et al.  Insulin therapy improves endothelial function in type 2 diabetes. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  E. Mannarino,et al.  Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. , 2004, Atherosclerosis.

[19]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[20]  F. Perticone,et al.  Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. , 2001, Diabetes.

[21]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[22]  A Mari,et al.  Estimation of the rate of appearance in the non-steady state with a two-compartment model. , 1992, The American journal of physiology.

[23]  M. Trovati,et al.  Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. , 2002, Journal of diabetes and its complications.

[24]  D. Papanicolaou,et al.  Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. , 1997, The Journal of clinical endocrinology and metabolism.

[25]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[26]  Robert R. Wolfe,et al.  Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis , 1992 .

[27]  A. Biggeri,et al.  Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. , 2004, Diabetes care.

[28]  Aroon D. Hingorani,et al.  Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans , 1999, Circulation.

[29]  M. Kelm,et al.  Additive Effect of Coexistent Type 2 Diabetes and Arterial Hypertension on Endothelial Dysfunction in Resistance Arteries of Human Forearm Vasculature , 2000, Angiology.

[30]  D. Singer,et al.  Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. , 2001, Diabetes care.

[31]  M. Makuuchi,et al.  Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. , 1998, The Journal of clinical investigation.

[32]  HanneleYki-Järvinen,et al.  Insulin Therapy Improves Endothelial Function in Type 2 Diabetes , 2000 .

[33]  C. Tack,et al.  Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone , 1998, Diabetologia.

[34]  Christopher J. Lyon,et al.  Insulin resistance and the endothelium , 2005, The American journal of medicine.

[35]  S. Jacob,et al.  Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. , 2000, Circulation.

[36]  E. Ferrannini,et al.  EFFECTS OF INSULIN ON THE CARDIOVASCULAR SYSTEM AND THE KIDNEY , 2004 .

[37]  W. Sheu,et al.  Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance. , 1994, Hypertension.

[38]  J. Ritter,et al.  Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes , 2000, Diabetologia.

[39]  T. Rabelink,et al.  Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate , 2002, Diabetologia.

[40]  K. Mather,et al.  Improved endothelial function with metformin in type 2 diabetes mellitus. , 2001, Journal of the American College of Cardiology.

[41]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[42]  P. Tsao,et al.  Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. , 2002, JAMA.

[43]  J. Kooner,et al.  C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites , 2001, Circulation.

[44]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[45]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[46]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[47]  R Hume,et al.  Prediction of lean body mass from height and weight , 1966, Journal of clinical pathology.

[48]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. , 1999, Circulation.

[49]  J. Halter,et al.  Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. , 1998, The Journal of clinical endocrinology and metabolism.

[50]  T. Shoji,et al.  Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. , 2001, Diabetes care.

[51]  C. Mogensen.  The kidney and hypertension in diabetes mellitus , 1989, Springer US.

[52]  C. Lamendola,et al.  Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein , 2002, Circulation.

[53]  E. Ferrannini,et al.  Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. , 1997, Circulation.

[54]  G. Watts,et al.  Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. , 1996, Clinical science.

[55]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[56]  G. D. Johnston,et al.  Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.